Cutera Inc. (CUTR, Financial), a renowned medical device company, witnessed a significant stock movement with its price diving 5.15%. The share price reached $0.556 with a trading volume of 193,783 shares and a turnover rate of 0.96%. The stock showed a volatility amplitude of 7.45%.
Recent financial reports reveal Cutera's revenue at $34.38 million, with a net loss of $24.68 million. The earnings per share stood at -$1.23, and the gross profit was $6.27 million. The price-to-earnings ratio is currently -0.07. In terms of analyst ratings, 25% of the four rating institutions recommend buying the stock, while 75% advise holding. No analysts suggested selling the stock.
The medical device industry, where Cutera operates, experienced an overall decline of 0.35%. Notably, related companies such as Nuwellis, Inc., Integra LifeSciences, and Biosig Technologies, Inc. saw substantial increases. Stocks like Nuwellis, Inc., Catheter Precision, Inc., and Tenon Medical, Inc. displayed high activity with turnover rates of 4379.20%, 62.14%, and 38.74%, respectively. Companies with significant volatility included Nuwellis, Inc., Baird Medical Investment Holdings Ltd, and Catheter Precision, Inc., showing amplitudes of 156.61%, 30.73%, and 25.59%, respectively.
Cutera Inc. is a key player in the medical equipment space, focusing on the design, development, manufacturing, marketing, and servicing of laser and aesthetic energy systems globally. Its product lineup includes enlighten, excel HR, excel V, Xeo, and Trusculpt 3D, marketed under various brand names. The majority of its revenue is derived from its U.S. division. The company's products are utilized by medical professionals for a range of procedures, including acne treatment, body sculpting, skin rejuvenation, hair and tattoo removal, and treatment of benign pigmented and vascular lesions.
